Evogene Ltd.

NASDAQ: EVGN · Real-Time Price · USD
1.34
-0.02 (-1.47%)
At close: Aug 15, 2025, 3:49 PM
1.35
0.37%
After-hours: Aug 15, 2025, 04:00 PM EDT

Evogene Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
7.5M 15.3M 11.32M 9.48M 11.91M 20.77M 27.33M 20.23M 23M 28.98M 31.86M 28.87M 36.01M 32.33M 37.63M 42.76M 38.64M
Short-Term Investments
2.35M 10K 8.64M 11.42M 14.7M 10.29M 9.9M 13.64M 5.79M 6.38M 6.09M 6.38M 8.54M 21.54M 23.96M 22.61M 31.45M
Long-Term Investments
80K 82K 95K 100K 133K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 10K
Other Long-Term Assets
1.67M 12K 39K 30K 26K 28K 106K 53K 74K 74K 21K 24K 25K 25K 25K 12K 10K
Receivables
3.29M 1.49M 3.95M 4.07M 539K 671K 1.34M 178K 250K 803K 452K 111K 166K 1.17M 151K 208K 219K
Inventory
2.15M 1.82M 1.46M 794K 716K 1.69M 113K 249K 591K 566K 165K 162K 172K 92K -1.86M -2.29M -2.58M
Other Current Assets
1.21M 1.3M n/a n/a n/a 1.75M n/a n/a n/a 32K n/a n/a n/a 8K n/a n/a n/a
Total Current Assets
16.5M 21.59M 25.36M 25.77M 31.02M 34.47M 40.55M 35.72M 31.41M 37.75M 40.77M 37.7M 47.63M 56.89M 63.6M 67.87M 72.89M
Property-Plant & Equipment
4.1M 4.25M 2.18M 2.38M 2.67M 3.44M 3.66M 3.91M 4.09M 4.07M 4.21M 4.3M 4.36M 4.18M 4.32M 3.98M 3.97M
Goodwill & Intangibles
11.96M 12.2M 12.44M 12.69M 12.92M 13.17M 13.41M 13.66M 13.9M 14.14M 14.38M 14.63M 14.87M 15.21M 15.44M 15.68M 15.91M
Total Long-Term Assets
17.8M 18.27M 14.76M 15.19M 15.76M 16.63M 17.19M 17.62M 18.07M 18.38M 18.62M 18.96M 19.25M 19.41M 19.79M 19.67M 19.89M
Total Assets
34.3M 39.86M 40.11M 40.97M 46.78M 51.1M 57.75M 53.34M 49.48M 56.13M 59.39M 56.66M 66.88M 76.3M 83.39M 87.54M 92.78M
Account Payables
592K 1.23M 1.2M 957K 77K 1.78M 1.18M 1.08M 1.15M 1.04M 977K 1.32M 1.35M 1.46M 1.85M 1.2M 993K
Deferred Revenue
562K 683K 1.52M 548K 977K 362K 1.37M 933K 239K 101K 454K 142K 241K 264K 150K 170K 170K
Short-Term Debt
10.37M 10.37M 10.32M n/a n/a n/a n/a n/a n/a 884K n/a n/a n/a n/a n/a n/a n/a
Other Current Liabilities
1.17M 2.88M 6.38M 1.5M 964K 1.41M 1.66M 1.87M 1.23M 1.62M 1.04M 1.06M 1.2M 1.61M 1.25M 1.09M 1.17M
Total Current Liabilities
15.6M 18.7M 23.29M 5.89M 6.13M 6.94M 6.48M 6.39M 5.36M 5.63M 5.58M 5.54M 6.28M 6.88M 6.54M 5.33M 5.34M
Long-Term Debt
n/a n/a n/a 10.39M 10.34M 10.37M 10.29M 10.33M 10.31M 10.11M 10M n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
n/a 90K n/a n/a n/a -4.03M 494K 578K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Liabilities
6.31M 6.33M 4.59M 15.13M 15.27M 11.05M 15.4M 15.84M 15.62M 15.71M 15.51M 5.72M 5.87M 6M 6.09M 5.57M 5.33M
Total Liabilities
21.91M 25.03M 27.88M 21.03M 21.4M 17.99M 21.88M 22.23M 20.98M 21.34M 21.09M 11.27M 12.15M 12.88M 12.63M 10.89M 10.67M
Total Debt
12.96M 12.87M 11.01M 11.2M 11.34M 1.14M 11.53M 11.81M 11.95M 11.93M 11.93M 2.12M 2.5M 2.67M 2.71M 2.39M 2.35M
Common Stock
372K 363K 301K 287K 286K 286K 286K 237K 237K 235K 234K 234K 234K 234K 234K 231K 230K
Retained Earnings
-276.66M -274.07M -274.5M -266.87M -261.45M -257.59M -250.99M -247M -239.98M -233.71M -230.71M -224.16M -215.34M -207.07M -199.7M -192.09M -185.88M
Comprehensive Income
n/a n/a n/a n/a 269.45M 269.35M 269.21M 261.05M 261.83M 261.4M 261.05M 260.88M 260.64M 260.49M 260.16M 258.26M 257.18M
Shareholders Equity
-3.65M -1.45M -4.34M 3.07M 8.29M 12.05M 18.51M 14.29M 22.09M 27.93M 30.58M 36.95M 45.53M 54.03M 60.69M 66.4M 71.54M
Total Investments
2.43M 92K 8.73M 11.52M 14.83M 10.29M 9.9M 13.64M 5.79M 6.38M 6.09M 6.38M 8.54M 21.54M 23.96M 22.61M 31.46M